V
Vifor Pharma AG
SIX:VIFN
Vifor Pharma AG
SIX:VIFN
Price:
166.15 CHF
0.48%
Market Closed
Updated:
May 3, 2024
Vifor Pharma AG
Cash from Investing Activities
|
Vifor Pharma AG
Cash from Investing Activities Peer Comparison
Comparables:
NOVN
NLSP
ROG
S
SDZ
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
V
|
Vifor Pharma AG
SIX:VIFN
|
Cash from Investing Activities
-CHf48.8m
|
CAGR 3-Years
49%
|
CAGR 5-Years
50%
|
CAGR 10-Years
4%
|
|
|
Novartis AG
SIX:NOVN
|
Cash from Investing Activities
$5.6B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
NLS Pharmaceutics AG
NASDAQ:NLSP
|
Cash from Investing Activities
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Roche Holding AG
SIX:ROG
|
Cash from Investing Activities
-CHf10.6B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-23%
|
|
S
|
Sandoz Group AG
SIX:SDZ
|
Cash from Investing Activities
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Vifor Pharma AG's Cash from Investing Activities?
Cash from Investing Activities
-48.8m
CHF
-48.8m
CHF
Based on the financial report for Dec 31, 2021, Vifor Pharma AG's Cash from Investing Activities amounts to -48.8m CHF.
What is Vifor Pharma AG's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
4%
4%
The average annual Cash from Investing Activities growth rates for Vifor Pharma AG have been 49% over the past three years , 50% over the past five years , and 4% over the past ten years .
You don't have any saved screeners yet
